|
|
 |
Visit us at TCT '09 booth# 622
Come to our InspireMD Breakfast Meeting
The Role of the MGuard™ Stent in Thrombus Management during AMI Interventions
Chairman: Martin Leon, MD
Panel: Alexandre Abizaid, MD PhD, Antonio Colombo, MD, Peter J. Fitzgerald, MD, PhD, Jacek Legutko, MD, PhD, Chaim Lotan, MD, Christian M. Spaulding, MD, PhD
6 Month MAGICAL STEMI Trial Results (D. Dudek)
Time and Location: Thursday, Sept. 24th at 07:00am
Moscone Convention Center: Room 132
|
|
|
 |
Visit us at TCTAP '09 booth# C16, Exhibition Room 2
InspireMD is delighted to present MGuard™:
-An innovative stent system designed for acute coronary syndromes.
|
 |
See Us Also At PCR 2009, Barcelona, Spain. May 19-22 Booth# F12
Coming Up At PCR 2009:
-MAGICAL Trial Results (STEMI Study Final Results Of Primary Endpoint
-FIM, One Year Follow-Up
-GUARD Study (Interim 30 Days Results With IVUS Analysis
|
|
InspireMD celebrated much success at TCT 2008, Washington DC,
USA. October 12-16, Booth #1411
-Meeting Chairman: Martin Leon MD
-WHEN: 7:00-8:00am, Thursday October 16
-WHERE: Room 143C, Washington Convention Center
|
|
BREAKFAST MEETING October 16th - TCT 2008
Meeting Topic: A New Approach to Treating Thrombus - Containing Lesions (SVG, AMI, and ACS)
-Meeting Chairman: Martin Leon MD
-WHEN: 7:00-8:00am, Thursday October 16
-WHERE: Room 143C, Washington Convention Center
|
|
InspireMD has the pleasure to invite you to the InspireMD Breakfast Meeting at TCT 2008.
This represents a rare opportunity for you to attend a meeting that will discuss the latest clinical data regarding the break
Key world renowned interventional cardiologists will lead the session and you will come away with a deep understanding as to how important the MGuard stent will be as a pioneering technology for the treatment of thrombus containing lesions.
Speakers: Alexandre Abizaid MD, Antonio Colombo MD, Gian-Battista Danzi MD, Dariusz Dudek MD, Eberhard Grube MD, Martin Leon, MD, Chaim Lotan MD, Carlo Di Mario MD, Gregory Pavlides MD.
|
|
Visit Us At ACC 2009, Orlando, FL, USA, March 29-31, Booth #3567
NEW Intriquing Clinical Results at ACC 09. Dr. Alexandre Abizaid. Sunday, March 29t
h at 5:30PM-5:42PM (Room W414D)
|
|
The “MGuard First in Man Trial - 30 Days’ Results.” Abstract
This abstract has been accepted for TCT 2008 as a poster. You may be able to view it as abstract number “484." where a full abstract will be available for view at TCT. To date, very promising 30 day and six months results have proven safety and efficacy of the MGuard.
MGuard is not available for sale in the United State
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|